vs
Axsome Therapeutics, Inc.（AXSM）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
ROYAL GOLD INC的季度营收约是Axsome Therapeutics, Inc.的1.9倍（$375.3M vs $196.0M），ROYAL GOLD INC净利率更高（24.9% vs -14.6%，领先39.5%），ROYAL GOLD INC同比增速更快（85.3% vs 65.0%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 58.8%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
AXSM vs RGLD — 直观对比
营收规模更大
RGLD
是对方的1.9倍
$196.0M
营收增速更快
RGLD
高出20.3%
65.0%
净利率更高
RGLD
高出39.5%
-14.6%
两年增速更快
AXSM
近两年复合增速
58.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $375.3M |
| 净利润 | $-28.6M | $93.6M |
| 毛利率 | — | 64.6% |
| 营业利润率 | -13.8% | 56.2% |
| 净利率 | -14.6% | 24.9% |
| 营收同比 | 65.0% | 85.3% |
| 净利润同比 | 61.9% | -12.8% |
| 每股收益（稀释后） | $-0.55 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMRGLD
| Q4 25 | $196.0M | $375.3M | ||
| Q3 25 | $171.0M | $252.1M | ||
| Q2 25 | $150.0M | $209.6M | ||
| Q1 25 | $121.5M | $193.4M | ||
| Q4 24 | $118.8M | $202.6M | ||
| Q3 24 | $104.8M | $193.8M | ||
| Q2 24 | $87.2M | $174.1M | ||
| Q1 24 | $75.0M | $148.9M |
净利润AXSMRGLD
| Q4 25 | $-28.6M | $93.6M | ||
| Q3 25 | $-47.2M | $126.8M | ||
| Q2 25 | $-48.0M | $132.3M | ||
| Q1 25 | $-59.4M | $113.5M | ||
| Q4 24 | $-74.9M | $107.4M | ||
| Q3 24 | $-64.6M | $96.2M | ||
| Q2 24 | $-79.3M | $81.2M | ||
| Q1 24 | $-68.4M | $47.2M |
毛利率AXSMRGLD
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | 73.6% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 69.4% | ||
| Q4 24 | — | 70.3% | ||
| Q3 24 | — | 66.6% | ||
| Q2 24 | — | 64.7% | ||
| Q1 24 | — | 58.4% |
营业利润率AXSMRGLD
| Q4 25 | -13.8% | 56.2% | ||
| Q3 25 | -27.0% | 64.4% | ||
| Q2 25 | -24.5% | 67.7% | ||
| Q1 25 | -46.9% | 63.6% | ||
| Q4 24 | -61.1% | 65.9% | ||
| Q3 24 | -59.8% | 61.3% | ||
| Q2 24 | -89.5% | 58.6% | ||
| Q1 24 | -89.7% | 50.7% |
净利率AXSMRGLD
| Q4 25 | -14.6% | 24.9% | ||
| Q3 25 | -27.6% | 50.3% | ||
| Q2 25 | -32.0% | 63.1% | ||
| Q1 25 | -48.9% | 58.7% | ||
| Q4 24 | -63.1% | 53.0% | ||
| Q3 24 | -61.7% | 49.7% | ||
| Q2 24 | -91.0% | 46.6% | ||
| Q1 24 | -91.1% | 31.7% |
每股收益（稀释后）AXSMRGLD
| Q4 25 | $-0.55 | $1.04 | ||
| Q3 25 | $-0.94 | $1.92 | ||
| Q2 25 | $-0.97 | $2.01 | ||
| Q1 25 | $-1.22 | $1.72 | ||
| Q4 24 | $-1.54 | $1.63 | ||
| Q3 24 | $-1.34 | $1.46 | ||
| Q2 24 | $-1.67 | $1.23 | ||
| Q1 24 | $-1.44 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $233.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $7.2B |
| 总资产 | $689.8M | $9.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMRGLD
| Q4 25 | $322.9M | $233.7M | ||
| Q3 25 | $325.3M | $172.8M | ||
| Q2 25 | $303.0M | $248.2M | ||
| Q1 25 | $300.9M | $240.8M | ||
| Q4 24 | $315.4M | $195.5M | ||
| Q3 24 | $327.3M | $127.9M | ||
| Q2 24 | $315.7M | $74.2M | ||
| Q1 24 | $331.4M | $137.9M |
总债务AXSMRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $50.0M | ||
| Q1 24 | — | — |
股东权益AXSMRGLD
| Q4 25 | $88.3M | $7.2B | ||
| Q3 25 | $73.7M | $3.4B | ||
| Q2 25 | $73.1M | $3.3B | ||
| Q1 25 | $53.2M | $3.2B | ||
| Q4 24 | $57.0M | $3.1B | ||
| Q3 24 | $92.9M | $3.0B | ||
| Q2 24 | $102.9M | $3.0B | ||
| Q1 24 | $144.0M | $2.9B |
总资产AXSMRGLD
| Q4 25 | $689.8M | $9.5B | ||
| Q3 25 | $669.3M | $4.5B | ||
| Q2 25 | $639.8M | $3.6B | ||
| Q1 25 | $596.7M | $3.5B | ||
| Q4 24 | $568.5M | $3.4B | ||
| Q3 24 | $561.5M | $3.3B | ||
| Q2 24 | $548.2M | $3.3B | ||
| Q1 24 | $545.7M | $3.3B |
负债/权益比AXSMRGLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | — |
| 自由现金流率自由现金流/营收 | -9.6% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 2.58× |
| 过去12个月自由现金流最近4个季度 | $-93.9M | — |
8季度趋势，按日历期对齐
经营现金流AXSMRGLD
| Q4 25 | $-18.7M | $241.7M | ||
| Q3 25 | $1.0M | $174.0M | ||
| Q2 25 | $-32.4M | $152.8M | ||
| Q1 25 | $-43.4M | $136.4M | ||
| Q4 24 | $-26.2M | $141.1M | ||
| Q3 24 | $-18.6M | $136.7M | ||
| Q2 24 | $-30.1M | $113.5M | ||
| Q1 24 | $-53.5M | $138.3M |
自由现金流AXSMRGLD
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | — | ||
| Q2 24 | $-30.2M | — | ||
| Q1 24 | $-53.6M | — |
自由现金流率AXSMRGLD
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | — | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | — | ||
| Q2 24 | -34.6% | — | ||
| Q1 24 | -71.4% | — |
资本支出强度AXSMRGLD
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率AXSMRGLD
| Q4 25 | — | 2.58× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.31× | ||
| Q3 24 | — | 1.42× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | — | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
暂无分部数据
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
